Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and Exchange Commission proxy filing. Compensation packages for executives ...

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

The spine pain industry is predicted to be valued at USD 8.03 billion by 2024. The lower back pain market size is estimated to be USD 13.08 billion by 2034, projected at a CAGR of 5%.The surge in the ...

NuVasive infringed five patents from a spine surgeon, a jury determined, according to an April 22 report from Bloomberg Law. The jury ruled that screw assemblies from the Reline, Armada and VuePoint ...

About Globus Medical, Inc. Globus Medical ... and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can ...

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the ...

Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In the fourth quarter, Globus's musculoskeletal sales improved 4.5% year over year. The growth was driven primarily by strong contributions from the company’s international spine business and a ...

Globus Medical GMED has been analyzed by 5 analysts ... which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include ...